Your session is about to expire
← Back to Search
Zanamivir for Type 2 Diabetes (NAED Trial)
NAED Trial Summary
This trial is testing whether the drug zanamivir can help improve the function of blood vessels in people with type 2 diabetes.
NAED Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNAED Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2009 Phase 3 trial • 64 Patients • NCT00784784NAED Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of asthma or chronic lung disease.I am on hormone replacement therapy.I am currently on immunosuppressant therapy.I have been diagnosed with type 2 diabetes by a doctor.You have had an allergic reaction to lactose or milk proteins in the past.My BMI is between 25 and 39.You drink more than 14 drinks a week if you're a man, or more than 7 drinks a week if you're a woman.I have a long-term kidney or liver disease.I have not received a nasal flu vaccine within 2 weeks before or plan to within 48 hours after taking zanamivir.You currently smoke or use tobacco products.My cancer is currently active.You have an autoimmune disease.I am between 45 and 64 years old.I have a history of heart disease, including heart attack or stroke.
- Group 1: Zanamivir treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What demographic is most suitable for inclusion in this clinical trial?
"This clinical trial is searching for 20 individuals aged 45-64, who have been clinically diagnosed with diabetes mellitus type 2. In addition to the age criteria, candidates must not belong to a vulnerable population (e.g., pregnant women or prisoners), have a BMI of 25-39 kg/m2 and be both male and female at randomization."
Is this trial open to adults who are 18 or older?
"Patients laying within the age range of 45 to 64 are able to participate in this medical trial. Meanwhile, there are 195 trials that cater especially for those below 18 years old and 1066 specifically designed for seniors above 65 year olds."
Is Zanamivir a reliable treatment option with minimal risk?
"Data collected from Phase 2 trials indicates that zanamivir is a fairly safe medication, scoring it a 2 on our assessment scale. However, efficacy remains unsubstantiated at this point in time."
Has Zanamivir been explored in other scientific investigations?
"Currently, three investigations are utilizing zanamivir with none in Phase 3. A majority of the trials for this medication take place in Columbia, Missouri but there are seven other sites conducting research as well."
Are there any opportunities right now to join this research study?
"Data found on clinicaltrials.gov confirms that this study is currently seeking participants, having been first posted on July 14th 2021 and revised most recently on June 6th 2022."
How many individuals have joined the experiment thus far?
"Assent. According to information presented on clinicaltrials.gov, this experiment is currently enrolling subjects and was initially posted on July 14th 2021. The most recent update was made June 6th 2022 and the study requires 20 volunteers at one site location."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger